1. Signs and symptoms that distinguish detrusor underactivity from mixed detrusor underactivity and bladder outlet obstruction in male patients. Issue 4 (22nd January 2018) Authors: Gammie, Andrew; Kaper, Mathilde; Steup, Achim; Yoshida, Satoshi; Dorrepaal, Caroline; Kos, Ton; Abrams, Paul Journal: Neurourology and urodynamics Issue: Volume 37:Issue 4(2018:Apr.) Page Start: 1501 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. What are the additional signs and symptoms in patients with detrusor underactivity and coexisting detrusor overactivity?. Issue 7 (10th April 2018) Authors: Gammie, Andrew; Kaper, Mathilde; Steup, Achim; Yoshida, Satoshi; Dorrepaal, Caroline; Kos, Ton; Abrams, Paul Journal: Neurourology and urodynamics Issue: Volume 37:Issue 7(2018:Sep.) Page Start: 2220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: results of a noninferiority, randomized, phase IIIb trial. (August 2015) Authors: Batista, Jose E.; Kölbl, Heinz; Herschorn, Sender; Rechberger, Tomasz; Cambronero, Javier; Halaska, Michael; Coppell, Alex; Kaper, Mathilde; Huang, Moses; Siddiqui, Emad Journal: Therapeutic advances in urology Issue: Volume 7:Number 4(2015:Aug.) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Issue 3 (March 2018) Authors: McQuade, Jennifer L; Daniel, Carrie R; Hess, Kenneth R; Mak, Carmen; Wang, Daniel Y; Rai, Rajat R; Park, John J; Haydu, Lauren E; Spencer, Christine; Wongchenko, Matthew; Lane, Stephen; Lee, Dung-Yang; Kaper, Mathilde; McKean, Meredith; Beckermann, Kathryn E; Rubinstein, Samuel M; Rooney, Isabell... Journal: Lancet oncology Issue: Volume 19:Issue 3(2018) Page Start: 310 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Three-year pooled analysis of factors associated with clinical outcomes across dabrafenib and trametinib combination therapy phase 3 randomised trials. (September 2017) Authors: Schadendorf, Dirk; Long, Georgina V.; Stroiakovski, Daniil; Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion-Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Dutriaux, Caroline; Gogas, Helen; Mandalà, Mario; Haanen, John B.A.G.; Lebbé, Céleste; Mackiewicz, Andrzej; Rutkowski, Pi... Journal: European journal of cancer Issue: Volume 82(2017) Page Start: 45 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗